CASETTI, ILARIA CAROLA
 Distribuzione geografica
Continente #
NA - Nord America 173
EU - Europa 91
AS - Asia 83
SA - Sud America 1
Totale 348
Nazione #
US - Stati Uniti d'America 172
CN - Cina 50
IE - Irlanda 36
IT - Italia 17
SG - Singapore 15
FI - Finlandia 14
DE - Germania 13
SE - Svezia 4
CH - Svizzera 3
IN - India 3
JO - Giordania 3
KR - Corea 3
GB - Regno Unito 2
IR - Iran 2
JP - Giappone 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CA - Canada 1
HK - Hong Kong 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
Totale 348
Città #
Ashburn 39
Dublin 36
Chandler 29
New York 24
Boardman 16
Helsinki 14
Shanghai 12
Singapore 10
Beijing 9
Nanjing 6
Princeton 5
Cagliari 4
Gallarate 4
Lawrence 4
Amman 3
Brugherio 3
Dongjak-gu 3
Lugano 3
Medford 3
Nanchang 3
Washington 3
Wilmington 3
Bengaluru 2
Boston 2
Fiesole 2
Frankfurt am Main 2
Hangzhou 2
Hebei 2
Jacksonville 2
Jiaxing 2
Mundelein 2
Pavia 2
Seattle 2
Tianjin 2
Amsterdam 1
Buffalo 1
Changsha 1
Chicago 1
Dubai 1
Falkenstein 1
Foshan 1
Guangzhou 1
Jinan 1
Lahore 1
Leawood 1
Miyazaki 1
Mumbai 1
Ningbo 1
Peshawar 1
Qingdao 1
Rizhao 1
Shenyang 1
Shijiazhuang 1
São Paulo 1
Tokyo 1
Toronto 1
Woodbridge 1
Totale 283
Nome #
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms 65
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin 56
Genomic profiling and genotype-phenotype correlations in myeloproliferative neoplasms 54
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis 47
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms 22
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms 21
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 18
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients 18
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis 16
Isolated congenital asplenia: An overlooked cause of thrombocytosis 16
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms 12
COVID-19 in Patients with Hematologic Diseases 11
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms 10
Totale 366
Categoria #
all - tutte 2.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 2 0 1 3 0 0
2020/202111 0 0 0 2 0 2 0 1 6 0 0 0
2021/202220 0 0 0 2 0 0 1 0 1 2 4 10
2022/202391 9 5 2 8 6 8 0 0 33 0 18 2
2023/2024168 17 14 9 5 18 63 7 13 3 3 11 5
2024/202543 17 18 3 4 1 0 0 0 0 0 0 0
Totale 366